82 research outputs found
Utilidad de la farmacogenética para predecir la eficacia y seguridad de la risperidona en el tratamiento de esquizofrenia
Tesis doctoral inĂ©dita. Universidad AutĂłnoma de Madrid, Facultad de Ciencias, Departamento de BiologĂa. Fecha de lectura: 13-05-201
Association between genetic polymorphisms and response to anti-TNFs in patients with inflammatory bowel disease
Tumor necrosis factor (TNF) is a major proinflammatory cytokine involved in the immune
response in inflammatory bowel disease (IBD). Anti-TNF drugs such as infliximab and adalimumab
are used to treat IBD; however, approximately 30% of patients do not respond to treatment. Individual
genetic differences could contribute to lack of efficacy. Genetic studies have tried to uncover the
factors underlying differences in response, however, knowledge remains limited, and the results
obtained should be validated, so that pharmacogenetic information can be applied in clinical practice.
In this review, we gather current knowledge in the pharmacogenetics of anti-TNF drugs in patients
with IBD. We observed a connection between the major genes described as possible predictors of
response to anti-TNF drugs in IBD and the cytokines and molecules involved in the T helper (Th)
17 pathwayThis study was supported by FundaciĂłn TeĂłfilo Hernando. RocĂo Prieto-PĂ©rez has a grant
from Universidad AutĂłnoma de Madrid (research personnel in training (FPI) program 2013)
A unique missense mutation in the RING domain impairs MID1 E3 ubiquitin ligase activity and localisation and is associated with uncommon Opitz Syndrome-like signs
MID1/TRIM18 is a member of the RING-containing Tripartite Motif family of E3 ubiquitin ligases. MID1 mutations cause X-linked Opitz Syndrome (XLOS), a neurodevelopmental genetic disease. We detected a Cys56Arg substitution in a family with history of midline developmental defects as the first variant identified in MID1 catalytic RING domain. This variant affects MID1 ubiquitin E3 activity and alters MID1 subcellular localisation and microtubule dynamics in a unique manner if compared to the other XLOS-associated mutations. Our data suggest that the relationship between MID1 activity and its cellular distribution is a crucial issue to fully understand MID1 physio-pathological role
Copy number variation analysis in the context of electronic medical records and large-scale genomics consortium efforts
The goal of this paper is to review recent research on copy number variations (CNVs) and their association with complex and rare diseases. In the latter part of this paper, we focus on how large biorepositories such as the electronic medical record and genomics (eMERGE) consortium may be best leveraged to systematically mine for potentially pathogenic CNVs, and we end with a discussion of how such variants might be reported back for inclusion in electronic medical records as part of medical history
Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications
Inherited retinal diseases (IRDs), defined by dysfunction or progressive loss of photoreceptors,
are disorders characterized by elevated heterogeneity, both at the clinical and genetic levels. Our
main goal was to address the genetic landscape of IRD in the largest cohort of Spanish patients
reported to date. A retrospective hospital-based cross-sectional study was carried out on 6089 IRD
affected individuals (from 4403 unrelated families), referred for genetic testing from all the Spanish
autonomous communities. Clinical, demographic and familiar data were collected from each patient,
including family pedigree, age of appearance of visual symptoms, presence of any systemic findings
and geographical origin. Genetic studies were performed to the 3951 families with available DNA
using different molecular techniques. Overall, 53.2% (2100/3951) of the studied families were
genetically characterized, and 1549 different likely causative variants in 142 genes were identified. The
most common phenotype encountered is retinitis pigmentosa (RP) (55.6% of families, 2447/4403).
The most recurrently mutated genes were PRPH2, ABCA4 and RS1 in autosomal dominant (AD),
autosomal recessive (AR) and X-linked (XL) NON-RP cases, respectively; RHO, USH2A and RPGR in
AD, AR and XL for non-syndromic RP; and USH2A and MYO7A in syndromic IRD. Pathogenic variants
c.3386G > T (p.Arg1129Leu) in ABCA4 and c.2276G > T (p.Cys759Phe) in USH2A were the most frequent
variants identified. Our study provides the general landscape for IRD in Spain, reporting the largest
cohort ever presented. Our results have important implications for genetic diagnosis, counselling and
new therapeutic strategies to both the Spanish population and other related populations.Ministerio de Salud EspañaComunidad de Madri
Recommended from our members
IBC CARe Microarray Allelic Population Prevalences in an American Indian Population
Background: The prevalence of variant alleles among single nucleotide polymorphisms (SNPs) is not well known for many minority populations. These population allele frequencies (PAFs) are necessary to guide genetic epidemiology studies and to understand the population specific contribution of these variants to disease risk. Large differences in PAF among certain functional groups of genes could also indicate possible selection pressure or founder effects of interest. The 50K SNP, custom genotyping microarray (CARe) was developed, focusing on about 2,000 candidate genes and pathways with demonstrated pathophysiologic influence on cardiovascular disease (CVD). Methods: The CARe microarray was used to genotype 216 unaffected controls in a study of pre-eclampsia among a Northern Plains, American Indian tribe. The allelic prevalences of 34,240 SNPs suitable for analysis, were determined and compared with corresponding HapMap prevalences for the Caucasian population. Further analysis was conducted to compare the frequency of statistically different prevalences among functionally related SNPs, as determined by the DAVID Bioinformatics Resource. Results: Of the SNPs with PAFs in both datasets, 9.8%,37.2% and 47.1% showed allele frequencies among the American Indian population greater than, less than and either greater or less than (respectively) the HapMap Caucasian population. The 2,547 genes were divided into 53 functional groups using the highest stringency criteria. While none of these groups reached the Bonferroni corrected p value of 0.00094, there were 7 of these 53 groups with significantly more or less differing PAFs, each with a probability of less than 0.05 and an overall probability of 0.0046. Conclusion: In comparison to the HapMap Caucasian population, there are substantial differences in the prevalence among an American Indian community of SNPs related to CVD. Certain functional groups of genes and related SNPs show possible evidence of selection pressure or founder effects
Recommended from our members
Two Variants of the C-Reactive Protein Gene Are Associated with Risk of Pre-Eclampsia in an American Indian Population
Background: The etiology of pre-eclampsia (PE) is unknown; but it is accepted that normal pregnancy represents a distinctive challenge to the maternal immune system. C-reactive protein is a prominent component of the innate immune system; and we previously reported an association between PE and the CRP polymorphism, rs1205. Our aim was to explore the effects of additional CRP variants. The IBC (Cardiochip) genotyping microarray focuses on candidate genes and pathways related to the pathophysiology of cardiovascular disease. Methods: This study recruited 140 cases of PE and 270 matched controls, of which 95 cases met criteria as severe PE, from an American Indian community. IBC array genotypes from 10 suitable CRP SNPs were analyzed. A replication sample of 178 cases and 427 controls of European ancestry was also genotyped. Results: A nominally significant difference (p value <0.05) was seen in the distribution of discordant matched pairs for rs3093068; and Bonferroni corrected differences (P<0.005) were seen for rs876538, rs2794521, and rs3091244. Univariate conditional logistic regression odds ratios (OR) were nominally significant for rs3093068 and rs876538 models only. Multivariate logistic models with adjustment for mother's age, nulliparity and BMI attenuated the effect (OR 1.58, P = 0.066, 95% CI 0.97–2.58) for rs876538 and (OR 2.59, P = 0.050, 95% CI 1.00–6.68) for rs3093068. An additive risk score of the above two risk genotypes shows a multivariate adjusted OR of 2.04 (P = 0.013, 95% CI 1.16–3.56). The replication sample also demonstrated significant association between PE and the rs876538 allele (OR = 1.55, P = 0.01, 95% CI 2.16–1.10). We also show putative functionality for the rs876538 and rs3093068 CRP variants. Conclusion: The CRP variants, rs876538 and rs3093068, previously associated with other cardiovascular disease phenotypes, show suggestive association with PE in this American Indian population, further supporting a possible role for CRP in PE
Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years.
Clonal hematopoiesis, especially that of indeterminate potential (CHIP), has been associated with age-related diseases, such as those contributing to a more severe COVID-19. Four studies have attempted to associate CHIP with COVID-19 severity without conclusive findings. In the present work, we explore the association between CHIP and COVID-19 mortality. Genomic DNA extracted from peripheral blood of COVID-19 patients (n = 241 deceased, n = 239 survivors) was sequenced with the Myeloid Solutions™ panel of SOPHiA Genetics. The association between clonality and age and clonality and mortality was studied using logistic regression models adjusted for sex, ethnicity, and comorbidities. The association with mortality was performed with patients stratified into four groups of age according to the quartiles of the distribution: 60–74 years, 75–84 years, 85–91 years, and 92–101 years. Clonality was found in 38% of the cohort. The presence of CHIP variants, but not the number, significantly increased with age in the entire cohort of COVID-19 patients, as well as in the group of survivors (p < 0.001). When patients were stratified by age and the analysis adjusted, CHIP classified as pathogenic/likely pathogenic was significantly more represented in deceased patients compared with survivors in the group of 75–84 years (34.6% vs 13.7%, p = 0.020). We confirmed the well-established linear relationship between age and clonality in the cohort of COVID-19 patients and found a significant association between pathogenic/likely pathogenic CHIP and mortality in patients from 75 to 84 years that needs to be further validated.post-print1034 K
Presence of rare potential pathogenic variants in subjects under 65Â years old with very severe or fatal COVID-19
Rare variants affecting host defense against pathogens could be involved in COVID-19 severity and may help explain fatal outcomes in young and middle-aged patients. Our aim was to report the presence of rare genetic variants in certain genes, by using whole exome sequencing, in a selected group of COVID-19 patients under 65 years who required intubation or resulting in death (n = 44). To this end, different etiopathogenic mechanisms were explored using gene prioritization-based analysis in which genes involved in immune response, immunodeficiencies or blood coagulation were studied. We detected 44 different variants of interest, in 29 different patients (66%). Some of these variants were previously described as pathogenic and were located in genes mainly involved in immune response. A network analysis, including the 42 genes with candidate variants, showed three main components, consisting of 25 highly interconnected genes related to immune response and two additional networks composed by genes enriched in carbohydrate metabolism and in DNA metabolism and repair processes. In conclusion, we have detected candidate variants that may potentially influence COVID-19 outcome in our cohort of patients. Further studies are needed to confirm the ultimate role of the genetic variants described in the present study on COVID-19 severityTis work was supported by Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation (COVID19 Research Call, COV20/00181) co-fnanced by European Development Regional Fund (FEDER, A way to
achieve Europe) and contributions from Estrella de Levante S.A. and Colabora Mujer Association. CIBERer
(Centro de InvestigaciĂłn en Red de Enfermedades Raras) is funded by Instituto de Salud Carlos III.R.L-R.and
M.dP.V. are sponsored by the project COV20/00181. M.C., P.M. and B.A. are supported by the Miguel Servet
(CP17/00006, CP16/00116) and Juan Rodes (JR17/00020) programs, respectively, of the Instituto de Salud Carlos
III, co-fnanced by the European Regional Development Fund (FEDER). R.R. is supported by a postdoctoral
fellowship of the Comunidad de Madrid (2019-T2/BMD-13714) and G.N.-M. by a contract of the Comunidad
de Madrid (PEJ-2020-AI/BMD-18610
- …